Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol

Kazuto Matsunaga, Hiroki Kawabata, Tsunahiko Hirano, Hisatoshi Sugiura, Yoshiaki Minakata, Masakazu Ichinose

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Combinations of inhaled corticosteroids (ICS) and inhaled long-acting beta2-agonists (LABA) have become widely used for the initiation of maintenance treatment for asthma. However, it has not been fully elucidated whether ICS/LABA alters the time-course of different control outcome measures in steroid-naive patients with asthma compared to the treatment with ICS alone.We compared the time-response in Asthma Control Questionnaire (ACQ), forced expiratory volume in 1 s (FEV1), exhaled nitric oxide fraction (FENO), and airway responsiveness to methacholine (PD200) between budesonide (BUD) and budesonide/formoterol (BUD/FM).BUD/FM therapy significantly improved the ACQ score at week 2 and week 4 (p < 0.01 and p < 0.05), and increased FEV1 and the methacholine threshold at week 8 and week 24 (all p < 0.05) compared to BUD alone. A logistic function model showed that the BUD/FM combination significantly improved ACQ, FEV1, FENO and PD200 at a faster rate than BUD over 24 weeks (p < 0.001 for ACQ, FEV1, PD200, and p < 0.05 for FENO, z-test). A significant variance in the time-response was also found in the outcomes of the two treatment groups (FENO and ACQ > FEV1 and PD200, p < 0.001, z-test).The present study provides evidence that ICS/LABA combination therapy results in a more rapid improvement in asthma symptoms, lung function, and airway inflammation compared to ICS monotherapy in steroid-naive patients with asthma.

Original languageEnglish
Pages (from-to)189-194
Number of pages6
JournalPulmonary Pharmacology and Therapeutics
Volume26
Issue number2
DOIs
Publication statusPublished - 2013 Apr
Externally publishedYes

Keywords

  • ACQ
  • AHR
  • Airflow limitation
  • Airway hyperresponsiveness
  • Airway inflammation
  • Asthma Control Questionnaire
  • BUD
  • Exhaled nitric oxide
  • FE
  • FM
  • PD

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Biochemistry, medical
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol'. Together they form a unique fingerprint.

Cite this